结构性心臟病器材市场规模、份额和成长分析（按产品、手术和地区划分）－2026-2033年产业预测

全球结构性心臟器材市场规模预计在 2024 年达到 155 亿美元，从 2025 年的 170.7 亿美元成长到 2033 年的 368.5 亿美元，在预测期（2026-2033 年）内复合年增长率为 10.1%。

全球结构性心臟器械市场正经历显着成长，这主要得益于系统性心臟病的高发生率。在美国，约有6000万成年人患有此类疾病（占成年人口的20-25%）。这凸显了这些器械在心臟病治疗中的重要作用。治疗方法包括多种经皮治疗方法，旨在控制后天性和先天性心臟病。经导管主动脉瓣置换术术（TAVR）等手术的医疗成本预计将会降低，从而提高其可及性并促进其普及，尤其是在老龄化人口寻求透过联邦医疗保险（Medicare）和医疗补助（Medicaid）获得更多医疗保障的情况下。产业领导者加大研发投入将推动创新，进一步增强结构性心臟器材市场的产品竞争力。

全球结构性心臟病器材市场成长要素

全球结构性心臟器材市场正经历显着成长，主要驱动因素是人口老化、缺乏运动和不健康饮食习惯导致的心臟衰竭盛行率不断上升。这些趋势推动了对各种心臟器械的需求，尤其是在老年族群中，主动脉瓣狭窄、二尖瓣逆流和先天性心臟疾病率不断上升。此外，随着医疗专业人员寻求有效治疗这些复杂心臟疾病的方法，对心臟机械工程领域先进技术的需求预计将持续增长，尤其关注包括静脉介入和封堵器在内的创新经导管疗法，这将进一步推动市场发展。

全球结构性心臟病器材市场限制因素

由于先进医疗技术和微创手术成本高昂，结构性心臟病器材市场面临严峻挑战。在医疗资源有限的地区，器械本身及其相关治疗的费用可能会限制许多患者，尤其是中低收入患者获得治疗的机会。这种经济障碍可能会阻碍市场成长和普及，因为患者难以负担必要的治疗费用。此外，某些地区的报销问题进一步加剧了这种情况，使患者无法寻求治疗，阻碍了市场的整体发展。

全球结构性心臟病器材市场趋势

全球结构性心臟病器材市场正经历重大变革，其主要驱动力是经导管主动脉瓣置换术术（TAVR）系统的日益普及。 TAVR作为一种治疗重度主动脉瓣狭窄的手段，尤其适用于不适合传统外科手术的患者，正逐渐受到青睐。 TAVR手术的微创特性带来了良好的临床疗效，从而推动了对这些先进器械的需求成长。为此，製造商正大力投资研发新一代TAVR系统，旨在扩大患者覆盖范围并改善治疗效果。这一趋势不仅标誌着结构性心臟疾病治疗方式的革新，也预示着整个市场将迎来强劲的成长动能。

目录

介绍

• 调查目标
• 市场定义和范围

调查方法

• 调查过程
• 二手资料和一手资料方法
• 市场规模估算方法

执行摘要

• 全球市场展望
• 市场主要亮点
• 细分市场概览
• 竞争格局概述

市场动态与展望

• 总体经济指标
• 驱动因素和机会
• 限制与挑战
• 供给面趋势
• 需求面趋势
• 波特的分析和影响

关键市场考察

• 关键成功因素
• 影响市场的因素
• 关键投资机会
• 生态系测绘
• 市场吸引力指数（2025）
• PESTEL 分析
• 价值链分析
• 定价分析
• 案例研究
• 监管环境
• 技术评估

全球结构性心臟病器材市场规模（依产品及复合年增长率划分）（2026-2033 年）

• 心臟瓣膜装置
  • 经导管心臟瓣膜
  • 外科心臟瓣膜
  • 生物瓣膜
  • 机械心臟瓣膜
• 闭合装置及输送系统
• 环状成形术环
• 配件
• 其他设备

全球结构性心臟病器材市场规模（依手术类型和复合年增长率划分）（2026-2033 年）

• 置换术
  • 经导管主动脉瓣置换术
  • SAVR手术
• 恢復
  • 结扎程序
  • 瓣环成形术
  • 瓣环成形

全球结构性心臟病器材市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Boston Scientific Corporation
• Medtronic
• Edwards Lifesciences Corporation
• Abbott Laboratories
• St. Jude Medical
• Biomerics
• Comed BV
• LivaNova PLC
• JenaValve Technology, Inc.
• CardioKinetix
• Lepu Medical Technology
• CryoLife
• Micro Interventional Devices
• Braile Biomedica
• TTK Healthcare

结论与建议

Global Structural Heart Devices Market size was valued at USD 15.5 Billion in 2024 and is poised to grow from USD 17.07 Billion in 2025 to USD 36.85 Billion by 2033, growing at a CAGR of 10.1% during the forecast period (2026-2033).

The global structural heart devices market is experiencing significant growth driven by the high prevalence of systemic heart diseases, affecting approximately 60 million individuals in the U.S., representing 20-25% of the adult population. This highlights the crucial role of these devices in addressing cardiac defects. Treatments encompass a variety of percutaneous therapies aimed at managing both acquired and congenital heart conditions. As healthcare costs for procedures like Transcatheter Aortic Valve Replacement (TAVR) are projected to improve, affordability will rise, encouraging adoption, particularly as the aging population seeks care covered by Medicare and Medicaid services. Increased investment in research and development by industry leaders fuels innovation, further enhancing product offerings and competition within the structural heart devices market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Structural Heart Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Structural Heart Devices Market Segments Analysis

Global Structural Heart Devices Market is segmented by Product, Procedure, and region. Based on Product, the market is segmented into Heart Valve Devices (Transcatheter Heart Valves, Surgical Heart Valves (Tissue Heart Valves, Mechanical Heart Valves)), Occluders & Delivery Systems, Annuloplasty Rings, Accessories, and Other Devices. Based on Procedure, the market is segmented into Replacement Procedures (TAVR Procedures, Savr Procedures), Repair Procedures (Closure Procedures, Annuloplasty, Valvuloplasty, TMVR Procedures). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Structural Heart Devices Market

The Global Structural Heart Devices market is experiencing significant growth driven by the rising prevalence of heart failure, largely attributed to an aging population, inactive lifestyles, and unhealthy dietary habits. These trends are resulting in a heightened need for various cardiac devices, especially as conditions like aortic stenosis, mitral regurgitation, and congenital heart defects are increasingly diagnosed among older individuals. Moreover, the demand for sophisticated advancements in cardiac mechanical engineering is expected to continue, with a particular focus on innovative transcatheter interventions, including vein treatments and occluders, further propelling the market forward as healthcare professionals seek effective solutions for these complex heart conditions.

Restraints in the Global Structural Heart Devices Market

The Global Structural Heart Devices market faces significant challenges due to the high costs associated with these advanced medical technologies and their minimally invasive procedures. In regions where healthcare support is limited, the expense of both the devices and the associated treatments can restrict access for many patients, particularly those in low- to middle-income brackets. This financial barrier can hinder market growth and adoption rates, as individuals may struggle to afford the necessary care. Moreover, reimbursement issues in certain areas further exacerbate the situation, dissuading patients from seeking treatment and impeding overall market progress.

Market Trends of the Global Structural Heart Devices Market

The Global Structural Heart Devices market is experiencing a significant shift driven by the growing adoption of Transcatheter Aortic Valve Replacement (TAVR) systems, which are increasingly favored for treating severe aortic stenosis, particularly among patients deemed unsuitable for conventional surgical interventions. The minimally invasive nature of TAVR procedures has garnered positive clinical outcomes, prompting heightened demand for these advanced devices. In response, manufacturers are making substantial investments in the development of next-generation TAVR systems, aiming to broaden patient eligibility and enhance treatment efficacy. This trend not only signifies an evolving approach to managing structural heart conditions but also indicates a robust growth trajectory for the market overall.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Technology Assessment

Global Structural Heart Devices Market Size by Product & CAGR (2026-2033)

• Market Overview
• Market Overview
• Heart Valve Devices
  • Transcatheter Heart Valves
  • Surgical Heart Valves
  • Tissue Heart Valves
  • Mechanical Heart Valves
• Occluders & Delivery Systems
• Annuloplasty Rings
• Accessories
• Other Devices

Global Structural Heart Devices Market Size by Procedure & CAGR (2026-2033)

• Market Overview
• Replacement Procedures
  • TAVR Procedures
  • SAVR Procedures
• Repair Procedures
  • Closure Procedures
  • Annuloplasty
  • Valvuloplasty

Global Structural Heart Devices Market Size & CAGR (2026-2033)

• North America (Product, Procedure)
  • US
  • Canada
• Europe (Product, Procedure)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Procedure)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Procedure)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Procedure)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• St. Jude Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomerics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Comed BV
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JenaValve Technology, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CardioKinetix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Micro Interventional Devices
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braile Biomedica
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TTK Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations